3 unknown, 1 completed, 1 not yet recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 1, Not yet recruiting 1 |
Follow MedRegen LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MRG-001 in Patients With Amyotrophic Lateral Sclerosis MRG-001 - Amyotrophic Lateral Sclerosis, Lou Gehrig Disease | Phase 2 | Unknown | MedRegen LLC | 10 | 2025-07-01 | 2024-08-23 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients MRG-001 (Low-dose), MRG-001 (High-dose), Placebo - Acute Respiratory Distress Syndrome, Respiratory Failure | Phase 2 | Unknown | MedRegen LLC | 60 | 2024-12-01 | 2024-08-23 |
| MRG-001 in Patients With Alcoholic Hepatitis MRG-001 - Alcoholic Hepatitis, Acute Alcoholic Hepatitis | Phase 2 | Not yet recruiting | MedRegen LLC | 32 | 2024-09-01 | 2024-03-13 |
| Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients MRG-001, Saline - Wound of Skin, Abdominal Wound | Phase 2 | Completed | MedRegen LLC | 10 | 2023-11-20 | 2025-09-08 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients MRG-001, Placebo - COVID-19, ARDS, Human | Phase 2 | Unknown | MedRegen LLC | 40 | 2021-12-01 | 2022-02-15 |
Respiratory Distress Syndrome (2) · Amyotrophic Lateral Sclerosis (1) · COVID-19 (1) · Cytokine Release Syndrome (1) · Hepatitis, Alcoholic (1) · Infections (1) · Liver Diseases, Alcoholic (1) · Motor Neuron Disease (1) · Respiratory Insufficiency (1) · Respiratory Tract Diseases (1)
Sodium Chloride (1)
United States (2)
Ali R Ahmadi, MD PhD (2) · Gordon R Bernard, MD (1) · Robert D Galiano, MD FACS (1) · Russell N Wesson, M.B.Ch.B (1)